Skip to content
DraconiticResearch
Search Sources API
194,161 studies31 sourcesUpdated 55 min ago
PreprintCC BY-NC-NDbioRxiv

Direct-to-Biology Strategy Accelerates CRBN-Targeting Molecular Glue Degrader Discovery

  • H. Chen1
  • Z. Shen
  • Q. Qu
  • J. Chen1
  • X. Guo
  • S. Han
  • W. Guo
  • W. Su
  1. 1Department of HTS and D2B, NCE Platform, IVBU, WuXi Biology, WuXi AppTec, China
Read full textPDFDOICite

Abstract

The authors have withdrawn this manuscript because a major revision is ongoing, and the timeline for a revised version is pending. Therefore, the authors do not wish this work to be cited as a reference for the project. If you have any questions, please contact the corresponding authors.

Related

  1. Molecular Editing in Protein Degradation: From a Dual NSD2/GSPT1 Degrader to an NSD2-Selective PROTAC and a GSPT1-Selective Molecular Glue
    W. Shen, Y. Liu, L. Liu +15
    bioRxivPreprintCC BYFull textOncologybioRxiv
  2. Targeting CD300a Signaling With a Phosphatidylserine‐Presenting Hydrogel Rescues Macrophage Dysfunction and Accelerates Diabetic Wound Healing
    Lele Wu, Xuetong Hao, Yang Zou +8
    Advanced Healthcare MaterialsPeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  3. 203 Dual targeting of uPAR and MICA/B with multiplexed-engineered CAR T cells offers a unique therapeutic strategy in fibrotic disease
    Hui-Yi Chu, Bahram Valamehr, Soheila Shirinbak +11
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  4. Discovery of compounds targeting human acute myeloid leukemia stem cells via a novel high-throughput screen
    I. A. Iasenza, S. Safa-Tahar-Henni, H. Dakik +10
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  5. Targeting BCL11B-mediated JAK2/STAT3 activation: A novel therapeutic strategy for Parkinson’s disease
    Wenwen Chen, Yejing Zhang, Xinrui Zhou +4
    iSciencePeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationNeurologyCell PressCrossrefEurope PMC

Cite

BibTeXRIS
BibTeX
@misc{chen2026directtobiology,
  title = {{Direct-to-Biology Strategy Accelerates CRBN-Targeting Molecular Glue Degrader Discovery}},
  author = {H. Chen and Z. Shen and Q. Qu and J. Chen and X. Guo and S. Han and W. Guo and W. Su},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.02.747152},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.02.747152v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - Direct-to-Biology Strategy Accelerates CRBN-Targeting Molecular Glue Degrader Discovery
AU  - H. Chen
AU  - Z. Shen
AU  - Q. Qu
AU  - J. Chen
AU  - X. Guo
AU  - S. Han
AU  - W. Guo
AU  - W. Su
PY  - 2026
DA  - 2026/09/02
PB  - bioRxiv
DO  - 10.64898/2026.09.02.747152
UR  - https://www.biorxiv.org/content/10.64898/2026.09.02.747152v1
AB  - The authors have withdrawn this manuscript because a major revision is ongoing, and the timeline for a revised version is pending. Therefore, the authors do not wish this work to be cited as a reference for the project. If you have any questions, please contact the corresponding authors.
ER  -